We are live on
!
Find out more
RS
R Squared Portfolio holdings
AUM
$190M
1-Year Est. Return
25.89%
This Fund
S&P 500
This Quarter
Est. Return
+15.51%
1 Year Est. Return
+25.89%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$190M
AUM Growth
+$8.35M
(+4.6%)
Cap. Flow
-$4.65M
Cap. Flow
% of AUM
-2.44%
Top 10 Holdings %
Top 10 Hldgs %
14.08%
Holding
725
New
248
Increased
120
Reduced
140
Closed
216
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.3M |
| 2 |
Penumbra
PEN
|
+$2.89M |
| 3 |
Intuitive Surgical
ISRG
|
+$1.9M |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.71M |
| 5 |
Costco
COST
|
+$1.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HOLX
Hologic
HOLX
|
+$5.96M |
| 2 |
Apple
AAPL
|
+$3.04M |
| 3 |
Micron Technology
MU
|
+$2.56M |
| 4 |
Eli Lilly
LLY
|
+$2.13M |
| 5 |
Visa
V
|
+$1.95M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.35% |
| 2 | Technology | 17.3% |
| 3 | Industrials | 15.96% |
| 4 | Healthcare | 11.59% |
| 5 | Consumer Discretionary | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SGMO
676
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| – | – |
-89,866
| Closed | -$22.2K |
|
677
SI-BONE Inc
SIBN
$835M
| – | – |
-16,566
| Closed | -$209K |
|
678
SoFi Technologies
SOFI
$23.9B
| – | – |
-23,274
| Closed | -$370K |
|
679
SoundHound AI
SOUN
$2.99B
| – | – |
-18,860
| Closed | -$130K |
|
680
Sphere Entertainment
SPHR
$5.14B
| – | – |
-2,152
| Closed | -$253K |
|
|
STKL
681
DELISTED
SunOpta
STKL
| – | – |
-13,336
| Closed | -$86.4K |
|
682
Stryker
SYK
$118B
| – | – |
-839
| Closed | -$276K |
|
683
Third Coast Bancshares
TCBX
$747M
| – | – |
-10,052
| Closed | -$380K |
|
684
TransDigm Group
TDG
$64B
| – | – |
-526
| Closed | -$610K |
|
685
ThredUp
TDUP
$351M
| – | – |
-10,331
| Closed | -$33.9K |
|
686
Teradyne
TER
$52.9B
| – | – |
-1,117
| Closed | -$331K |
|
687
Target
TGT
$74.5B
| – | – |
-4,806
| Closed | -$582K |
|
688
Alpha Teknova
TKNO
$389M
| – | – |
-14,376
| Closed | -$41.5K |
|
689
TransUnion
TRU
$16.3B
| – | – |
-3,026
| Closed | -$209K |
|
690
Trupanion
TRUP
$1.26B
| – | – |
-8,931
| Closed | -$229K |
|
691
Tenaris
TS
$28.4B
| – | – |
-6,246
| Closed | -$363K |
|
692
Taysha Gene Therapies
TSHA
$1.81B
| – | – |
-11,276
| Closed | -$50.4K |
|
693
Take-Two Interactive
TTWO
$40B
| – | – |
-1,153
| Closed | -$228K |
|
694
Ubiquiti
UI
$36.1B
| – | – |
-270
| Closed | -$213K |
|
695
UnitedHealth
UNH
$360B
| – | – |
-1,509
| Closed | -$408K |
|
|
696
Visa
V
$707B
| – | – |
-6,456
| Closed | -$1.95M |
|
697
Vale
VALE
$65.2B
| – | – |
-36,382
| Closed | -$579K |
|
698
Velocity Financial
VEL
$726M
| – | – |
-12,804
| Closed | -$232K |
|
699
Vista Energy
VIST
$8.25B
| – | – |
-3,752
| Closed | -$283K |
|
700
Viemed Healthcare
VMD
$343M
| – | – |
-14,071
| Closed | -$130K |
|
Similar funds
GWM
GP
EL
KFGG
BFG
AFP
CCC
NI
R Squared's Q2 2026 Portfolio in Review
As of Q2 2026, R Squared held 725 positions worth $190M, up 4.6% from $182M the previous quarter. Its ten largest holdings account for 14% of the portfolio.
R Squared's Q2 2026 filing shows 248 new, 120 increased, 140 reduced and 216 closed positions. Its largest new stake was Meta Platforms (Facebook): 2,795 shares worth $1.57M. The largest sale was Hologic, an estimated $5.96M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 18% a quarter earlier, followed by Technology and Industrials.
- R Squared's largest Q2 2026 buy was Meta Platforms (Facebook): 2,795 shares worth $1.57M.
- R Squared added most to NVIDIA in Q2 2026, an estimated $3.3M increase.
- R Squared's biggest Q2 2026 reduction was Apple, cutting an estimated $3.04M.
- R Squared fully exited Hologic in Q2 2026, selling an estimated $5.96M.
- R Squared's ten largest holdings make up 14% of its $190M portfolio in Q2 2026.
- R Squared opened 248 new positions and closed 216 in Q2 2026.
- R Squared's portfolio value rose 4.6% quarter-over-quarter to $190M.
Based on R Squared's 13F filing for Q2 2026, filed 5 Aug 2026.